China    manufacturer

Hangzhou AllTest Biotech CO.,LTD 

      Your Reliable Rapid Test Partner!

Sales & Support
Request A Quote - Email
Select Language
English
French
German
Italian
Russian
Spanish
Portuguese
Dutch
Greek
Japanese
Korean
Arabic
Turkish
China good quality Custom Monoclonal Antibody on sale China good quality Hybridoma Monoclonal Antibody on sale
I like the products and service provided by AllTest. They really take our interest into consideration.

—— Mr John Smith England

My oldest daughter actually has Lyme disease. She spent almost 1 year in a wheelchair because of Lyme. She is doing very well now. I used 2 of the samples. 1 to test my Lyme diagnosed daughter and 1 to test my daughter who does not have Lyme. Your tests worked well. My daughter with Lyme tested positive and the one who does not tested negative.

—— Ms Sheila

Whenever I have the requests,AllTest always give me the satisfied reply at the first time.

—— Mrs Julie Tschetter Belgium

I'm Online Chat Now

High Accurated Multi Drug Rapid Test B Midstream ( Oral Fluid ) for simultaneous

Product Details:

Place of Origin:CHINA
Brand Name:AllTest
Certification:CE
Model Number:Midstream

Payment & Shipping Terms:

Minimum Order Quantity:500
Packaging Details:25T/Kit
Supply Ability:100 Million a year
Detailed Product Description
Format: Midstream Specimen: Oral Fluid
Kit Size: 25T/Kit Cut-Off: 200ug/ml
Color: White Storage: 2-30°C

A rapid test for the simultaneous, qualitative detection of multiple drugs and drug metabolites in human saliva CE certified

 

 

Applications:

 

The Multi-Drug Rapid Test Midstream for AMP /MET /COC /OPI /THC /PCP /MTD /MDMA /OXY /COT /K2 /BZO/KET/BAR is a lateral flow chromatographic immunoassay for the qualitative detection of multiple drugs and drug metabolites in saliva at the following cut-off concentrations:

Test Calibrator Cut-off (ng/mL)
Benzodiazepines (BZO) Oxazepam 30
Amphetamine (AMP) d-Amphetamine 50
Methamphetamine (MET) d-Methamphetamine 50
Marijuana (THC) 11-nor-D9 -THC-9 COOH 50
Phencyclidine (PCP) Phencyclidine 10
Cocaine (COC) Benzoylecgonine 20
Opiates (OPI/MOP) Morphine 40
Methadone (MTD) Methadone 30
Oxycodone (OXY) Oxycodone 20
Cotinine(COT) Cotinine 20
Methylenedioxymethamphetamine(MDMA) d,l-Methylenedioxymethamphetamine 50
Synthetic Marijuana(K2) JWH -018, JWH- 073 25
Ketamine(KET) Ketamine 50
Barbiturates(BAR) Secobarbital 50

This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) and gas chromatography/tandem mass spectrometry (GC/MS/MS) are the preferred confirmatory methods. Professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.

 

 

Description:

 

The Multi-Drug Rapid Test Midstream for AMP /MET /COC /OPI /THC /PCP /MTD /MDMA /OXY /COT /K2 /BZO/KET/BAR and their metabolites is a rapid, saliva screening test that can be performed without the use of an instrument. The test utilizes monoclonal antibodies to selectively detect elevated levels of specific drugs in human saliva

Amphetamine (AMP)

Amphetamine is a sympathomimetic amine with therapeutic indications. The drug is often self-administered by nasal inhalation or oral ingestion. Depending on the route of administration, amphetamine can be detected in oral fluid as early as 5-10 minutes following use1. Amphetamine can be detected in oral fluids for up to 72 hours after use1.

The amphetamine assay contained within the Multi-Drug Rapid Test Midstream yields a positive result when the amphetamine concentration in oral fluid exceeds 50ng/ml.

Methamphetamine (MET)

Methamphetamine is a potent stimulant chemically related to amphetamine but with greater CNS stimulation properties. The drug is often self-administered by nasal inhalation, smoking or oral ingestion. Depending on the route of administration, methamphetamine can be detected in oral fluid as early as 5-10 minutes following use.Methamphetamine can be detected in oral fluids for up to 72 hours after use1.

The Methamphetamine assay contained within the Multi-Drug Rapid Test Midstream yields a positive result when the methamphetamine concentration in oral fluid exceeds 50ng/ml.

Cocaine (COC)

Cocaine is a potent central nervous system (CNS) stimulant and a local anesthetic derived from the coca plant (erythroxylum coca). The drug is often self-administered by nasal inhalation, intravenous injection and free-base smoking. Depending on the route of administration, cocaine and metabolites benzoylecgonine and ecgonine methyl ester can be detected in oral fluid as early as 5-10 minutes following use1.Cocaine and benzoylecgonine can be detected in oral fluids for up to 24 hours after use1.

The cocaine assay contained within the Multi-Drug Rapid Test Midstream for cocaine and opiates yields a positive result when the cocaine metabolite in oral fluid exceeds 20ng/ml.

Opiates (OPI/MOP)

The drug class opiates refers to any drug that is derived from the opium poppy, including naturally occurring compounds such as morphine and codeine and semi-synthetic drugs such as heroin. Opiates act to control pain by depressing the central nervous system. The drugs demonstrate addictive properties when used for sustained periods of time; symptoms of withdrawal may include sweating, shaking, nausea and irritability. Opiates can be taken orally or by injection routes including intravenous, intramuscular and subcutaneous; illegal users may also take the intravenously or by nasal inhalation. Using an immunoassay cutoff level of 40 ng/ml, codeine can be detected in the oral fluid within 1 hour following a single oral dose and can remain detectable for 7-21 hours after the dose2. Heroin metabolite 6-monoacetylmorphine (6-MAM) is found more prevalently in excreted unmetabolized, and is also the major metabolic product of codeine and heroin.

The opiates assay contained within the Multi-Drug Rapid Test Midstream yields a positive result when the opiates concentration in oral fluid exceeds 40 ng/ml.

Marijuana (THC)

11-nor-D9-tetrahydrocannabinol-9-carboxylic acid (D9-THC-COOH), the metabolite of THC (D9-tetrahydrocannabinol), is detectable in saliva shortly after use. The detection of the drug is thought to be primarily due to the direct exposure of the drug to the mouth (oral and smoking administrations) and the subsequent sequestering of the drug in the buccal cavity3. Historical studies have shown a window of detection for THC in saliva of up to 14 hours after drug use3.

The THC assay contained within the Multi-Drug Rapid Test Midstream yields a positive result when the D9-tetrahydrocannabinol concentration in oral fluid exceeds 50ng/ml.

Phencyclidine (PCP)

Phencyclidine, the hallucinogen commonly referred to as Angel Dust, can be detected in saliva as a result of the exchange of the drug between the circulatory system and the oral cavity. In a paired serum and saliva sample collection of 100 patients in an Emergency Department, PCP was detected in the saliva of 79 patients at levels as low as 2 ng/ml and as high as 600 ng/ml4.

The PCP assay contained within the Multi-Drug Rapid Test Midstream yields a positive result when the PCP concentration in oral fluids exceeds 10ng/ml.

Methadone (MTD)

Methadone is a narcotic analgesic prescribed for the management of moderate to severe pain and for the treatment of opiate dependence (heroin, Vicodin, Percocet, morphine).

Methadone is a long acting pain reliever producing effects that last from twelve to forty-eight hours. Ideally, methadone frees the client from the pressures of obtaining illegal heroin, from the dangers of injection, and from the emotional roller coaster that most opiates produce. Methadone, if taken for long periods and at large doses, can lead to a very long withdrawal period. The withdrawals from methadone are more prolonged and troublesome than those provoked by heroin cessation, yet the substitution and phased removal of methadone is an acceptable method of detoxification for patients and therapists.

The MTD assay contained within the Multi-Drug Rapid Test Midstream yields a positive result when the MTD concentration in saliva exceeds 30ng/ml.

Oxycodone (OXY)

Oxycodone is a semi-synthetic opioid with a structural similarity to codeine. The drug is manufactured by modifying thebaine, an alkaloid found in the opium poppy. Oxycodone, like all opiate agonists, provides pain relief by acting on opioid receptors in the spinal cord, brain, and possibly directly in the affected tissues. Oxycodone is prescribed for the relief of moderate to high pain under the well-known pharmaceutical trade names of OxyContin®, Tylox®, Percodan® and Percocet®. While Tylox®, Percodan® and Percocet® contain only small doses of oxycodone hydrochloride combined with other analgesics such as acetaminophen or aspirin, OxyContin consists solely of oxycodone hydrochloride in a time-release form. Oxycodone is known to metabolize by demethylation into oxymorphone and noroxycodone.

The OXY assay contained within the Multi-Drug Rapid Test Midstream yields a positive result when the OXY concentration in saliva exceeds 20ng/ml.

Cotinine (COT)

Cotinine is the first-stage metabolite of nicotine, a toxic alkaloid that produces stimulation of the autonomic ganglia and central nervous system when in humans. Nicotine is a drug to which virtually every member of a tobacco-smoking society is exposed whether through direct contact or second-hand inhalation. In addition to tobacco, nicotine is also commercially available as the active ingredient in smoking replacement therapies such as nicotine gum, transdermal patches and nasal sprays.

Although nicotine is excreted in saliva, the relatively short half-life of the drug makes it an unreliable maker for tobacco use. Cotinine, however, demonstrates a substantially longer half-life than nicotine bears a high correlation with plasma cotinine levels and has been found to be the best maker for smoking status compared with saliva nicotine measurement, breath carbon monoxide testing and plasma thiocyanate testing. The window of detection for cotinine in saliva at a cutoff level of 20 ng/ml is expected to be up to 1-2 days after nicotine use.

Methylenedioxymethamphetamine (MDMA)

Methylenedioxymethamphetamine (ecstasy) is a designer drug first synthesized in 1914 by a German drug company for the treatment of obesity. Those who take the drug frequently report adverse effects, such as increased muscle tension and sweating. MDMA is not clearly a stimulant, although it has, in common with amphetamine drugs, a capacity to increase blood pressure and heart rate. MDMA does produce some perceptual changes in the form of increased sensitivity to light, difficulty in focusing, and blurred vision in some users. Its mechanism of action is thought to be via release of the neurotransmitter serotonin. MDMA may also release dopamine, although the general opinion is that this is a secondary effect of the drug (Nichols and Oberlender, 1990). The most pervasive effect of MDMA, occurring in virtually all people who took a reasonable dose of the drug, was to produce a clenching of the jaws.

The MDMA assay contained within the Multi-Drug Rapid Test Midstream yields a positive result when the MDMA concentration in saliva exceeds 50ng/ml.

Synthetic Marijuana (K2)

Synthetic Marijuana or K2 is a psychoactive herbal and chemical product that, when consumed, mimics the effects of Marijuana. It is best known by the brand names K2 and Spice, both of which have largely become genericized trademarks used to refer to any synthetic Marijuana product. The studies suggest that synthetic marijuana intoxication is associated with acute psychosis, worsening of previously stable psychotic disorders, and also may have the ability to trigger a chronic (long-term) psychotic disorder among vulnerable individuals such as those with a family history of mental illness.

Elevated levels of oral fluid/saliva metabolites are found within hours of exposure and remain detectable window up to 24-48 hours after smoking (depending on usage/dosage).

The K2 assay contained within the Multi-Drug Rapid Test Midstream yields a positive result when the K2 concentration in saliva exceeds 20ng/ml

Benzodiazepines (BZO)

Benzodiazepines are medications that are frequently prescribed for the symptomatic treatment of anxiety and sleep disorders. They produce their effects via specific receptors involving a neurochemical called gamma aminobutyric acid (GABA). Because they are safer and more effective, Benzodiazepines have replaced Barbiturates in the treatment of both anxiety and insomnia. Benzodiazepines are also used as sedatives before some surgical and medical procedures, and for the treatment of seizure disorders and alcohol withdrawal. Risk of physical dependence increases if Benzodiazepines are taken regularly (e.g., daily) for more than a few months, especially at higher than normal doses. Stopping abruptly can bring on such symptoms as trouble sleeping, gastrointestinal upset, feeling unwell, loss of appetite, sweating, trembling, weakness, anxiety and changes in perception.

The BZO assay contained within the Multi-Drug Rapid Test Midstream yields a positive result when the BZO concentration in saliva exceeds 30ng/ml..

Ketamine (KET)

Ketamine is a dissociative anesthetic developed in 1963 to replace PCP (Phencyclidine). While Ketamine is still used in human anesthesia and veterinary medicine, it is becoming increasingly abused as a street drug. Ketamine is molecularly similar to PCP and thus creates similar effects including numbness, loss of coordination, sense of invulnerability, muscle rigidity, aggressive / violent behavior, slurred or blocked speech, exaggerated sense of strength, and a blank stare. There is depression of respiratory function but not of the central nervous system, and cardiovascular function is maintained. The effects of Ketamine generally last 4-6 hours following use .

The KET assay contained within the Multi-Drug Rapid Test Midstream yields a positive result when the KET concentration in saliva exceeds 50ng/ml

Barbiturates (BAR)

Barbiturates are CNS depressants. They are used therapeutically as sedatives, hypnotics, and anticonvulsants barbiturates are almost always taken orally as capsules or tablets. The effects resemble those of intoxication with alcohol. Chronic use of barbiturates leads to tolerance and physical dependence.

Short-acting barbiturates taken at 400 mg/day for 2-3 months can produce a clinically significant degree of physical dependence. Withdrawal symptoms experienced during periods of drug abstinence can be severe enough to cause death.

The approximate detection time limits for barbiturates are:

Short acting (e.g.Secobarbital) 100mgPO(oral) 4.5days

Long acting(e.g.Phenobarbital) 400mgPO(oral) 7days

The BAR assay contained within the Multi-Drug Rapid Test Midstream yields a positive result when the BAR concentration in saliva exceeds 50ng/ml.

 

 

Principle:

 

The Multi-Drug Rapid Test Midstream for AMP /MET /COC /OPI /THC /PCP /MTD /MDMA /OXY /COT /K2 /BZO/KET/BAR is an immunoassay based on the principle of competitive binding. Drugs that may be present in the oral fluid specimen compete against their respective drug conjugate for binding sites on their specific antibody.

During testing, a portion of the oral fluid specimen migrates upward by capillary action. A drug, if present in the oral fluid specimen below its cut-off concentration, will not saturate the binding sites of its specific antibody. The antibody will then react with the drug-protein conjugate and a visible colored line will show up in the test line region of the specific drug strip. The presence of drug above the cut-off concentration in the oral fluid specimen will saturate all the binding sites of the antibody. Therefore, the colored line will not form in the test line region.

A drug-positive oral fluid specimen will not generate a colored line in the specific test line region of the strip because of drug competition, while a drug-negative oral fluid specimen will generate a line in the test line region because of the absence of drug competition.

To serve as a procedural control, a colored line will always appear at the control line region, indicating that proper volume of specimen has been added and membrane wicking has occurred.

 

 

How to use?

 

Allow the test Midstream, specimen, and/or controls to reach room temperature(15-30°C) prior to testing. Instruct the donor to not place anything in the mouth including food, drink, gum or tobacco products for at least 10 minutes prior to collection.

1. Remove the test midstream from the sealed pouch and use it within one hour.

2. Insert the absorbent wick to the mouth and put it under the tongue to collect oral fluid until the control line appears.

3. Place the test midstream on a clean and level surface. See illustration below.

4. Read results at 10 minutes. Do not read results after 15 minutes.High Accurated Multi Drug Rapid Test B Midstream ( Oral Fluid ) for simultaneous

 

 

INTERPRETATION OF RESULTS

 

(Please refer to the previous illustration)

*NEGATIVE:* A colored line appears in the Control region (C) and colored lines appear in the Test region (T). This negative result indicates that the drug concentration is below the detectable level.

*NOTE: The shade of color in the test line region (Drug/T) will vary, but it should be considered negative whenever there is even a faint line.

POSITIVE: A colored line appears in the Control region (C). No line appears in the test region (Drug/T). The positive result means that the drug concentration in the oral fluid sample is greater than the designated cut-off for a specific drug.

INVALID: Control line fails to appear. Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for control line failure. Review the procedure and repeat the test using a new test Midstream . If the problem persists, discontinue using the lot immediately and contact the manufacturer.

 

 

QUALITY CONTROL

 

A procedural control is included in the test. A colored line appearing in the control region (C) is considered an internal procedural control. It confirms sufficient specimen volume, adequate membrane wicking and correct procedural technique.

Contact Details
Hangzhou AllTest Biotech CO.,LTD

Tel:86-571-56267891

Fax:86-571-56267856

Contact Person: Mrs. Selina

Send your inquiry directly to us (0 / 3000)